Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06643312 · ClinicalTrials.gov registry record · NA

TPAD for Recovery of Standing After Severe SCI

A NA study of SCI - Spinal Cord Injury, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06643312: Recruiting NA study of SCI - Spinal Cord Injury, sponsored by Kessler Foundation.

NCT06643312 is a NA study of SCI - Spinal Cord Injury that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 50 participants, above the 34-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06643312, a NA study of SCI - Spinal Cord Injury, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate how standing and sitting balance control is altered after spinal cord injury (SCI) and how a new type of robotic assistive device may be used to improve muscle function. This device is called the Tethered Pelvic Assist Device, or TPAD. The main aims are to: 1\. Examine muscle activation patterns generated during different types of standing in spinal cord injured individuals using robotic assistance or self-assistance for balance 2 and 3. Examine the effectiveness of robotic-assisted stand training in the improvement of posture control during different types of standing and sitting in spinal cord injured individuals. Participants will be placed into one of 5 groups based on a physical classification of their spinal cord injury: Group 1: * Individuals with SCI that can stand independently * Will receive TPAD training * Will undergo standing, posture, sitting, and stepping assessments * Participation in this group will last about six months Group 2: * Individuals with SCI that cannot stand independently * Will receive TPAD training * Will undergo standing, posture, sitting, and stepping assessments * Participation in this group will last about 6 months Group 3: * Individuals with SCI that can stand independently * Will undergo standing and posture assessments * Participation in this group will last about 2 weeks Group 4: * Individuals with SCI that cannot stand independently * Will undergo standing and posture assessments * Participation in this group will last about 2 weeks Group 5: * Individuals without a SCI * Will undergo standing, posture, and sitting assessments * Participation in this group will last about 2 weeks

Primary Outcome

Research participants will sit on a padded table and perform tasks to challenge their balance control (reaching/shifting weight in multiple directions). Assistance for sitting will be provided at the trunk by the TPAD or by the trainer. EMG and kinematic analysis will be performed on the lower extremities, trunk and upper extremities during sitting. The trunk force and position controller data from the TPAD will be also collected; these data will be synchronized with EMG and kinematic data. Musc

Conditions Studied

Interventions

  • DEVICE The Tethered Pelvic Assist Device (TPAD)

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-10-22
Est. Completion 2028-01
Phase NA
Kessler Foundation

104 total trials

What NCT06643312 shows while recruiting

NCT06643312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 34-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (47% higher).

The record links to 1 condition, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which The Tethered Pelvic Assist Device (TPAD) is the first listed.

NCT06643312 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06643312 about?

NCT06643312 is a clinical study titled "TPAD for Recovery of Standing After Severe SCI". The purpose of this study is to investigate how standing and sitting balance control is altered after spinal cord injury (SCI) and how a new type of robotic assistive device may be used to improve muscle function. This device is called the Tethered Pelvic Assist Device, or TPAD. The main aims are t...

What is the current status of trial NCT06643312?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-10-22. Estimated completion is 2028-01.

What conditions does trial NCT06643312 study?

This clinical trial studies the following conditions: SCI - Spinal Cord Injury.

What interventions are being tested in trial NCT06643312?

The interventions under investigation include: The Tethered Pelvic Assist Device (TPAD) (DEVICE).

Who is sponsoring clinical trial NCT06643312?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06643312 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for SCI - Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06643312's enrollment target sits among peer trials

50 3rd of 13 higher than 9 of 13 other SCI - Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other SCI - Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06643312, the US trial registry maintained by the National Library of Medicine. NCT06643312 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.